-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
White Paper
Generating the Right Evidence to Fuel Funding in Pharmaceutical Innovation
Ten critical points for life sciences companies to consider when generating and delivering the right evidence to attract necessary funding from investors.
Jun 07, 2022
Capital investment is the life blood of pharmaceutical innovation, and it is critical for driving research and development (R&D) and accelerating commercial success for the life sciences industry. However, attracting the necessary capital is challenging as investors have a plethora of options to choose from in a highly competitive marketplace when making investment decisions.
Additionally, financial analysts are more inquisitive than ever when making their recommendations. Having access to and utilizing the right clinical and commercial evidence is a prerequisite for attracting capital funding and investments to secure commercial success. Many mistakes are made, for example, when the wrong data is chosen, overly optimistic market assumptions about market size are developed, or forecasting overlooks the impact of rigorous payer control.
Read the white paper to learn about ten critical points for life sciences companies to consider when generating and delivering the right evidence to inspire favorable analyst reviews and attract necessary funding from investors.